Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeted Therapies for Pancreatic Cancer
Idoroenyi Amanam, Vincent Chung
Cancers (2018) Vol. 10, Iss. 2, pp. 36-36
Open Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

Apatinib: A Review in Advanced Gastric Cancer and Other Advanced Cancers
Lesley J. Scott
Drugs (2018) Vol. 78, Iss. 7, pp. 747-758
Closed Access | Times Cited: 199
Opportunities and delusions regarding drug delivery targeting pancreatic cancer-associated fibroblasts
Huiqin Liu, Yu Shi, Feng Qian
Advanced Drug Delivery Reviews (2021) Vol. 172, pp. 37-51
Closed Access | Times Cited: 59
Proimmunogenic impact of MEK inhibition synergizes with agonist anti-CD40 immunostimulatory antibodies in tumor therapy
Daniel Baumann, Tanja Hägele, Julian Mochayedi, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 60
Cancer drug resistance: A fleet to conquer
Showket Hussain, Ankita Singh, Sheeraz Un Nazir, et al.
Journal of Cellular Biochemistry (2019) Vol. 120, Iss. 9, pp. 14213-14225
Closed Access | Times Cited: 57
Novel EPR-enhanced strategies for targeted drug delivery in pancreatic cancer: An update
Vahideh Mohammadzadeh, Niloufar Rahiman, Seyedeh Maryam Hosseinikhah, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 73, pp. 103459-103459
Closed Access | Times Cited: 30
Morphologic and Molecular Landscape of Pancreatic Cancer Variants as the Basis of New Therapeutic Strategies for Precision Oncology
Chiara Bazzichetto, Claudio Luchini, Fabiana Conciatori, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8841-8841
Open Access | Times Cited: 43
Sonication tailored enhance cytotoxicity of naringenin nanoparticle in pancreatic cancer: design, optimization, and in vitro studies
Md Habban Akhter, Sandeep Kumar, Shibli Nomani
Drug Development and Industrial Pharmacy (2020) Vol. 46, Iss. 4, pp. 659-672
Closed Access | Times Cited: 41
SGLT2 promotes pancreatic cancer progression by activating the Hippo signaling pathway via the hnRNPK-YAP1 axis
Dianyun Ren, Yan Sun, Dan Zhang, et al.
Cancer Letters (2021) Vol. 519, pp. 277-288
Closed Access | Times Cited: 40
A systematic review and meta-analysis of the association between circulating tumor DNA (ctDNA) and prognosis in pancreatic cancer
Deniz Can Güven, Taha Koray Şahin, Hasan Cagri Yildirim, et al.
Critical Reviews in Oncology/Hematology (2021) Vol. 168, pp. 103528-103528
Closed Access | Times Cited: 36
Combination Therapy with a Bispecific Antibody Targeting the hERG1/β1 Integrin Complex and Gemcitabine in Pancreatic Ductal Adenocarcinoma
Tiziano Lottini, Claudia Duranti, Jessica Iorio, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 2013-2013
Open Access | Times Cited: 14
Ribosomal protein L10 in mitochondria serves as a regulator for ROS level in pancreatic cancer cells
Jun Yang, Zongmeng Chen, Nan Liu, et al.
Redox Biology (2018) Vol. 19, pp. 158-165
Open Access | Times Cited: 41
The Novel Roles of Connexin Channels and Tunneling Nanotubes in Cancer Pathogenesis
Silvana Valdebenito, Emil Lou, John Baldoni, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 5, pp. 1270-1270
Open Access | Times Cited: 40
Tumor selective uptake of drug-nanodiamond complexes improves therapeutic outcome in pancreatic cancer
Vijay Sagar Madamsetty, Añil Sharma, Maria A. Toma, et al.
Nanomedicine Nanotechnology Biology and Medicine (2019) Vol. 18, pp. 112-121
Open Access | Times Cited: 38
Small molecule inhibitors in pancreatic cancer
Ju‐Feng Sun, Cecilia C. Russell, Christopher J. Scarlett, et al.
RSC Medicinal Chemistry (2020) Vol. 11, Iss. 2, pp. 164-183
Open Access | Times Cited: 36
The Latest Advancement in Pancreatic Ductal Adenocarcinoma Therapy: A Review Article for the Latest Guidelines and Novel Therapies
Marwa Elsayed, Maen Abdelrahim
Biomedicines (2021) Vol. 9, Iss. 4, pp. 389-389
Open Access | Times Cited: 31
The roles of lncRNAs and miRNAs in pancreatic cancer: a focus on cancer development and progression and their roles as potential biomarkers
Somayeh Jafari, Hossein Motedayyen, Parisa Javadi, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
Advancing Targeted Therapies in Pancreatic Cancer: Leveraging Molecular Aberrations for Therapeutic Success
Tanvi Gupta, Mohd Murtaza
Progress in Biophysics and Molecular Biology (2025)
Closed Access
Contributions of Low-frequency-mutated Genes in Pancreatic Tumorigenesis and Their Implications in Precision Cancer Therapy
Shih‐Han Hsu, Tzu-Lei Kuo, Ming‐Chuan Hsu, et al.
Journal of Cancer Research and Practice (2025) Vol. 12, Iss. 1, pp. 1-5
Open Access
Undaria pinnatifida fucoidan nanoparticles loaded with quinacrine attenuate growth and metastasis of pancreatic cancer
Samar M. Etman, Radwa A. Mehanna, Amany Abdel-Bary, et al.
International Journal of Biological Macromolecules (2020) Vol. 170, pp. 284-297
Closed Access | Times Cited: 29
Targeting of claudin-4 by Clostridium perfringens enterotoxin-conjugated polysialic acid nanoparticles for pancreatic cancer therapy
Man Kyu Shim, Jinhee Na, In Kyung Cho, et al.
Journal of Controlled Release (2021) Vol. 331, pp. 434-442
Closed Access | Times Cited: 26
Immune Stimulating Antibody‐Photosensitizer Conjugates via Fc‐Mediated Dendritic Cell Phagocytosis and Phototriggered Immunogenic Cell Death for KRAS‐Mutated Pancreatic Cancer Treatment
Dahye Kim, Sanghee Lee, Kun Na
Small (2021) Vol. 17, Iss. 10
Closed Access | Times Cited: 26
Post-translational down-regulation of Nrf2 and YAP proteins, by targeting deubiquitinases, reduces growth and chemoresistance in pancreatic cancer cells
Margherita Grattarola, Marie Angèle Cucci, Antonella Roetto, et al.
Free Radical Biology and Medicine (2021) Vol. 174, pp. 202-210
Closed Access | Times Cited: 25
Overexpressed WDR3 induces the activation of Hippo pathway by interacting with GATA4 in pancreatic cancer
Wenjie Su, Shikai Zhu, Kai Chen, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 24
Green synthesis and structural characterization of gold nanoparticles from Achillea wilhelmsii leaf infusion and in vitro evaluation
Maryam Asariha, Azam Chahardoli, Nadia Karimi, et al.
Bulletin of Materials Science (2020) Vol. 43, Iss. 1
Closed Access | Times Cited: 25
LMO7 as an Unrecognized Factor Promoting Pancreatic Cancer Progression and Metastasis
Xinjian Liu, Hao Yuan, Jing Zhou, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top